Strategic Opportunity Discovery for In-Licensing
 

​For pharmaceutical and biotechnology companies seeking to expand their pipelines, identifying the most attractive in-licensing opportunities requires deep visibility across a rapidly evolving global innovation landscape.

​

SAGEIQ enables systematic discovery of promising assets that align with a company’s strategic priorities.

​

The platform can be configured to search globally for opportunities based on parameters such as:

• therapeutic area focus
• development stage
• modality or technology platform
• mechanism of action
• geographic availability
• competitive positioning

​

Through SAGEIQ, clients gain access to a continuously updated intelligence view of emerging opportunities across biotechnology companies, academic institutions, and emerging technology platforms.

​

The result is a prioritized opportunity map highlighting the most strategically relevant assets for potential in-licensing or collaboration.